AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2020 Issue 3; Ask the Editor
Long-Term Use of Insulin with Trulicity or Victoza (GLP-1 Receptor Agonist)
What codes should be assigned for long-term use of both an injectable GLP-1 receptor agonist drug, such as Trulicity or Victoza as well as insulin? ...
Subscribe or sign in to view the full article.
Article Overview
This short article addresses ICD-10-CM coding for long-term medication therapy involving insulin and an injectable GLP-1 receptor agonist such as Trulicity or Victoza. It is intended for coders and billing staff who need a quick reference for medication-status reporting and general code selection context.
Why This Topic Matters
Medication-status coding can affect how a patient’s ongoing therapy is captured in the medical record and on claims. This note provides a concise reference for situations involving concurrent long-term use of insulin and another injectable diabetes-related drug class.
What You Will Learn
- The article’s focus on long-term medication therapy coding
- How the topic relates to insulin and injectable GLP-1 receptor agonist therapy
- The general context for documenting ongoing drug use in ICD-10-CM records
- Why concurrent medication status coding may be relevant in practice
Who Should Read This
- Medical coders
- Billing staff
- Clinical documentation specialists
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com